| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82e13d7b8d746346727e63b385e7e3d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a112fa5dd8cc717ee8bdb5e4004d0b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33dcd8256634893431e42dc326db18fe |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-119
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-155 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0619
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0793
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-30 |
| filingDate |
2011-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e1630cb8ef67c1591efcbd45d555e2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64f35e4e12ca82fcb371999100a5b43c |
| publicationDate |
2013-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013108669-A1 |
| titleOfInvention |
Dopaminergic neurons differentiated from pluripotent stem cells and uses of thereof |
| abstract |
The present invention provides populations of neural cells derived from pluripotent cells, and methods for making and using the same. Disclosed herein are methods for generating dopaminergic neurons in vitro using a combination of agents that cause differentiation of the pluripotent cells into dopaminergic neurons. Also disclosed are methods for treating a neurodegenerative disease in a patient by generating dopaminergic neurons in vitro, and transplanting them into the brain of the patient, such that the dopaminergic neurons are sufficient to reduce or eliminate the symptoms of the neurodegenerative disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016138392-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10711243-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11104881-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10287546-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9968637-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10260041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11560546-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11649431-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015084908-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10280398-B2 |
| priorityDate |
2010-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |